hoodwitharipiprazole.DevelopmentalMedicineandChildNeurology,
2009,51(1),74
12null }?,aò;,|k?,?.- ?'':í 8`??Dú ?at
ì "543. "5ú DD?,2007;17(5):333
13nullFindingRL,ShortEJ,LeskovecT,etal.Aripiprazoleinchildrenwith
attentiondeficit/hyperactivitydisorder.JournalofChildandAdolescent
Psychopharmacology,2008,18(4):347
14nullFindingRL,KauffmanRE,SalleeFR,etal.TolerabilityandPhar-
macokineticsofAripiprazoleinChildrenandAdolescentswithPsychia-t
ricDisordersAnOpen-Labe,lDose-EscalationStudy.Journalof
ClinicalPsychopharmacology,2008,28(4):441
15nullStrawnJR,DelgadoSV.Successfultreatmentofcatatoniawitharip-i
prazoleinanadolescentwithpsychosis.JournalofChildandAdolescent
Psychopharmacology,2007,17(5):733
16nullStiglerKA,PoseyDJ,McDougleCJ.Aripiprazoleformaladaptivebe-
haviorinpervasivedevelopmentaldisorders.JournalofChildandAdo-
lescentPsychopharmacology,2004,14(3):455
17nullLogueDD,GonzalezN,HeligmanSD,etal.Hyperglycemiaina7-
year-oldchildtreatedwitharipiprazole.AmericanJournalofPsychia-
try,2007,164(1):173
18nullDhamijaR,VermaR.Diabeticketoacidosisinducedbyaripiprazolein
12-year-oldboy.DiabetesCare,2008,31(6):50
19nullWahlR,OstroffR.Reversalofsymptomatichyperprolactinemiabyarip-
iprazole.AmericanJournalofPsychiatry,2005,162(8):1542
20nullMelhemS,KatzK,JamesonA,etal.Prolongedtoxicityin2-year-
oldafteraccidentalingestionofaripiprazole.PediatricEmergencyCare,
2009,25(2):105
21nullFindingRL.Atypicalantipsychotictreatmentofdisruptivebehaviordis-
ordersinchildrenandadolescents.JournalofClinicalPsychiatry,
2008,69(4):9
22nullBarrettE,BlondeL,ClementS,etal.Consensussevelopmentconfer-
enceonantipsychoticdrugsandobesityanddiabetes.DiabetesCare,
2004,27:596
ˉ?? g8 ?¥?D0í C
?_?
(??? gDy,??null300456)
Knull1nullˉ?? g8 ?hyˉ,Qˉ?T,? ?4?,"- í+r0tb?D0í ?hV?+?a#¨ê
;a "5?2? 3?_°?Z ?O£s?,;?×.d¥b£3ya)|?,?<?ó?|am!|a? /rá?
íE, μB?a ]b''óo
?h¥hyh? "5O£í Cb
1oMnullˉ?? g8 ?, g2, g,?D0í
?ms ?|:R988.2nullnullnullóDS M ?:AnullnullnullócI|:1006-5687(2011)02-0063-03
nullnullˉ?? g8 ?h(recurrentoralulcer,ROU)1
?¥a?????¥0V? ?,?ù?ˉ???
μ1K?,?h qúr20%P·, g8h¥ n
êb''hhyˉ,Qˉ?T,? ?4?,"- í+
r0t,-ùù r? ?Xb?Dí ?h?×
?í D? &í M2?,í
- ^ Fˉ
?Z ?μB?¥a ]b
1nullhyh
ˉ?? g8 ? ??Dnull g2nullanull gnullSb
null g2null- Sn?null=ünullbnull íùnull?Mv ?nullt:
null ?á?#, ?nullnull ?h g2, .5?ebnull·
g2[£1{ba ?}DE?μ ''aa M,null??
Enull gnullét:null g2,? 0???,y??r′,
O?? J,M
í?bnull·á′DD g2¥1
"bb? eò¥null
fD?null g2nulla1:null g2
? L£,??′e,/?|,òü.R ?á,?sO|
′ Le£7í-nullbnull p Wínull g nullt:null g2
?,á`ìF-?£7?9nullb[ sY· ? L
?#a/?| a??′eá′ A ?¥1''h
-h,?Ohpy7íbC}DE?ˉ?? g8
?¥hyhμ÷éB?¥a MbV#¨O£?
7y,?D.d ? ?a1: g1á-L, 1?- ì, /
? ?ó" '', H ???,y7 g8 ?¥?hD#
¨hM áMM1b g8 ? ù ? ?hM,?#¨?
?? y ^×1¥=y í,hê?1?á #b
? :[1]? q<? "£1o1sb′a L,′
1á′ /′ ?áb÷?D90ó¤DE?C?5
3[2]a1?h''h ù1?á ü£,?b?
6aíí9 ^×1¥?hy íbb? ,[3]? ù
ê?¥nullá? ?null ? ?,a1''hh?á?, ^yá
?′D,?/J,′ 7?,4??@? ^
''hh¥1ob?0?[4]G null íùnull B±?v
63??0DnullTianjinnullPharmacynull2011Mnull?23 ?2ù
là°ù:2011-02-18
?null?:null ,-/,|ú?-nullnull G5],?.?null¥
? ?a1,''hh''1í′ù,à3 %''hˉ?ù
5,A3 %í′, 7|ú @[<?null/?null- ?b|
ú?,D 3 ?,7a? 63?kaá(?)a /?í
?-?,#''h??kaá(?)a / ?Eí-b
2null "5í
2null1nulls?OínullO£s?í
^?D0í ˉ??
g8 ?¥?1ZEb? W?[5]|''hs17?í
:?? Hy?¨ ??Fh;á?£?¨v?
Fh;éùì?¨ 1I?Fh;á /′?¨ /?
Fh;á?′D?¨??mFh;? /|′?¨6
3 /?Fh;ó′| ??¨ ??1??Fhb2T
í 56 è,9μr q91.7%b??v[6]|''hs2?
í :?á£?¨?1??F?e=ao0;|′
??¨?1??F 31?a FVa?b2Tí
F55 è,9μr q94.5%b ù?B[7]|''hs3?í
:?á£?¨ ¥?Fh; /|′?¨ B?1?
Fh;ó ′?¨?óFhb2Tí 33 è,9
μr q87.9%b
2null2nullüZí nullt \?[8]?¨bí 60 è,
2T??22 è,Ar17 è,μr18 è,9μr q
95.0%b|£ó[9][?1????í 98 è,í?
59 è,μr32 è,9μr q92.9%b??|?[10][
)|?í 93 è,2Tí?42 è,z39 è,9
μr q87.1%b{Sü?[11][Pé B ,0í 40
è,2Tí?31 è,z8 è,9μr q97.5%bb
?[12]?¨F? ? ê?í |′??60 è,2T
Ar12 è,μr35 è,9μr q78.3%b ù??[13]
¨ 1 ,0F?í 45 è,2T:??22 è,Ar20
è,ír3 è,9μr q93.3%bé )[14]?¨?0
??í 32 è,2T:??6 è,Ar10 è,μr q
2 è,ír4 è,9μr q87.5%bá?-[15]?¨?
?mí 33 è,2T:í?21 è,Ar10 è,í
r2 è,9μr q93.94%b
2null3null1EZí null?DE? "5ü1EZí
, rgDb ù á??[16]1Eü?( 3?üa?
±a?0a]?a?Ia? ?a ?Iaèda R?a 31
?)í ''h45 èbO£Fh:ér?e?Fá?a
e?;ó? g m^n?F??a C?¤a6?;?P
> ? ó?Fù?ao0a ?)¥;vL Y2?Fv?;
ó ′?F?Ba+èa??aa ?;á?′e?F?
{a?S; /|′?F?Sa?0; /′?F ?1
?a?§b2T9μr q196.0%bú±r[17]1E
bk!|(?ùaWa=aüa?a 31?a??aì
?a FVa 6 ?a a?¥a 3?¤)í 32 è,9μ
r q190.6%b~ ? [18]¨b ??Z( 31?a ?
1?ò20g,é?aá?ò15g,o?0a??a
ò12g, 3 F?30g,e=9g)í ''h30 èb.e .
Ft= ?; g? .F R?a ? ê?;L YF ?¥a(
p;,μF=áb°14 £X?b2T:9μr q
83.3%b±£[19]¨ g8 ? ??A(c? ê?a ? ê
?a 31?a ?1?a FVao?0a 6 ?a??a 3?üa
?Sa? ?a?ù?)í ''h81 è,2T:9μr q
93.8%bf?[20]¨F????(]?a?¤ao0a§
Pa? ?ò10g, F?aa ?ò15g,%?3g)í ''h
40 èb2T:9μr q97.5%b
2null4null ?¨0nullI6ó?[21]¨??0a]a8
ˉab?F?x?4p?¨ò??), ?°4~6
Q,7d11? ?,í ''h50 è,9μr q1
96.0%b? ?[22]¨?#p4(ca#a%?),p?),
?°6Qí b7d11 ?,í ''h50 èb2T:
9μr q192.0%bá?V[23]¨!| 3?(c?]
=a X ?a ?Ia 3?¤aùa ),???), ?°4Q,
¨1?,í ''h58 è,2T:9μr q186.21%b
|0 á[24]¨± gêc ?A(á?a7 ?a??a?
ùaè?¤a ?a ?IaàP?)20m,l (c ?2min,
?°4Qb¨7d,í ''h30 è,2T:9μr q1
86.6%b
2null5null e Enull$ à[25][?O¥??0í ''h
30 è,Ar16 è,μr13 è,ír1 è,9μr q1
96.7%b? §£[26]?¨?0¥??Oí ''h30
è,Ar22 è,μr6 è,9μr qr93.0%b 6?,
"5?μ?¨b±?a B ????0í , r
Vb
3nulll2
í10?M ?,?D0ROU¥a MDí μB
?¥éZ, L V?+?a#¨ê ;a "5?2
? 3?_°?Z ?O£s?¥=?;í5¨0 ?
1 2,;?×.d¥b£3ya)|?,?<?
ó?|am!|a? /rá?íE; ? ?ù??í
m "?Z ?g|¤ B?¥?üb? "5ù
?? is?3 %¥ù5b n5, g8 ??he
y# ? ???b#,?áO£s?1?ˉ,ò£
?W?C= ó";?=,?S?S?μ, rS
i?v¥ ?i?,á PíE "5?é??
?;??,"-í ˉ?? g8 ?¥ "5??
,?h ? 3 ?#í ?¥ù??1 D;?
1,"- ?Cμ+s?¥0tb9-,?Dí
ROU]?ˉ?Z ?|¤ ?vl?,A U í
¥a ],??μ?éB? ìb
64??0DnullTianjinnullPharmacynull2011Mnull?23 ?2ù
? IóD
1null ? :.V A£ ?íˉ?? g8 ?¥ü.??D,2006,27
(3):322
2null?C?.? f90ó¤ g8 SD.2?:~ ê SD/ ?? ,
1990:278-280
3nullb? ,.??mF??0í ?%? g8 ?34 è.C}?D
0,2010,30(1):19
4null?0?.?? Y?? ]?F?í ˉ?? g8 ?33 è.?y
?D0,2010,41(1):50
5null? W?.Oíˉ?? g8 ?56 è.??r BóKnullD0 <,
2006,3(11):99
6null??v.e£i¨Eí ˉ?? g8 ?55 è.?Dù?,2009,22
(5):19
7null ù?B.O£í ˉ??^? g233 è.??D0,2008,27
(10):800
8nullt \, ù? ?.bí ˉ?? g8 ?¥ "543.DD ?
?D Ll?,2007,20(5):564
9null|£ó.?1????í ˉ?? g8 ?98 è.??D,
2007,26(3):164
10null??|, >?ü,o?§,?.)|?í ˉ?? g8 ?93
è r43.éìDDyD,2006,16(6):29
11null{Sü,?b?, `l ,.Pé B ,0F?í ˉ?? g8 ?
40 è.~?D0,2007,(6):38
12nullb ,?).F? ? ê?í |′??ˉ?? g8 ?60
è.?S?D2??,2007,27(7):662
13null ù??. 1 ,0F?í ˉ??-? e ?45 è.?S ?W
E,2009,17(3):32
14nullé ).?D2?í ˉ?? g8 ?32 è.; ü?D,2010,
25(4):668
15nullá?-.??mFhí ˉ?? g8 ?33 è "543.?~
?D?,2010,45(8):583
16null ù á?,|Z),|?.ü?í ?%? g8 ?45 è.C}?
D2??,2007,16(11):1503
17nullú±r.bk!|í ˉ?? g8 ?.??D,2007,23(3):
75
18null~ ?.?D2?í ˉ?? g8 ? r43.C}?D2
??,2009,18(30):3681
19null±£. g8 ? ??Aí ˉ?? g8 ?167 è "543.?D
0?,2009,15(7):33
20nullf?.F????í ˉ?? g8 ?40 è.?Dù?,2009,22
(2):40
21nullI6ó, >=0, ü?m.?0?4í g8 ?¥ r43.?S
uD =,2007,14(9):79
22null? ?.?#p4í ˉ??-? e ?íù r43.μ?D
?,2010,32(1):53
23nullá?V.!| 3??? A{£Eí g8 ?58 è "5ù?.
a?D?,2010,37(3):461
24null|0 á.± gêc ?Aí ˉ??-? ? ? "543.μ?D
?,2009,31(2):22
25null$W.?02?í ˉ?? g8 ? r43.?ó "5?,
2010,26(5):28
26null? §£.?D2?í ˉ?? g8 ?30 è.C}?D2?
?,2009,18(8):896
???0 Fé8??T¨ù?éZ
d?d
(?? g??Dy,??null300211)
nullnull?ms ?|:R975+.5nullnullnullóDS M ?:AnullnullnullócI|:1006-5687(2011)02-0065-04
nullnullé8??(hepaticfibrosis,HF) ^BM ¤?éh
¥]h ?D$,9 ^é?M¥ù¥Aü¨ ,
?25%~40%K??Z1é?? .àé′b20 W@
80M}aù[ ?, ?"é#%s ??!D 3?s0
3tD/ ?¥?Z?¨,?Cé8?? ^B?2?F
?¥???9 3V?, ^é%? 3ê μ??O
H,é#=[?e8?1?¥%?é ? ¥?V
9 3???Z?é??¥h ?V?b"-a1,é
8??¥? 3 ^B?? ?¥V?, ^é# ? ¥B
?7 ??Q?,iO ^ V[I¥b??é8??
?h¥<W?#2 (é??aé′)¥?×?,#
S=? 3tD?DD? 5×?á ??ù?é8??
¥? 3?Z?#]ín @b
"-a1 Fé8??¥| {?1 ?:null?"h
y;null]?é?%(HSC)¥;null\éé?%
¥ó§;null]?%?é(ECM)¥??;null\é
ECM¥?3;null]?é#?Q?;null1é%;null
y? eb
1null?DDé8??¥a M
?DDa1''hYè? A£afy??{S, =
"??,°òá A£2a|y=7??b A£{y
SU|8,h{ =,4[??,%ü°ò, A£27
65??0DnullTianjinnullPharmacynull2011Mnull?23 ?2ù
là°ù:2011-02-17
|
|